NN9535-4447 Epidemiological assessment of the risk for pancreatic cancer associated with the use of semaglutide in patients with type 2 diabetes- A cohort study based on Nordic registry data

ENCePP Code of conduct

Yes

Data sources

• Data source(s):
  Danish registries (access/analysis)

  Norwegian Health Registers
• Data source(s), other:
  Swedish health registers
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

  Other

Use of a Common Data Model (CDM)

• CDM mapping:
  Yes

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No